These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1982701)

  • 1. [Symposium on Converting Enzyme Inhibitors in Cardiovascular Diseases. Sao Paulo, 2 September 1989].
    Arq Bras Cardiol; 1990 Aug; 55 Suppl A():A1-22. PubMed ID: 1982701
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin converting enzyme inhibition: changing the course of cardiovascular disease. Proceedings of an international symposium. 22-24 October 1993, Barcelona, Spain.
    J Hypertens Suppl; 1994 Jul; 12(4):S1-104. PubMed ID: 7965268
    [No Abstract]   [Full Text] [Related]  

  • 3. Evolving role of angiotensin-converting enzyme inhibitors in cardiovascular therapy. Second International Symposium on Cilazapril. February 9 to 11, 1989, Basel, Switzerland. Proceedings.
    Am J Med; 1989 Dec; 87(6B):1S-99S. PubMed ID: 2532456
    [No Abstract]   [Full Text] [Related]  

  • 4. [ACE inhibitors in cardiovascular diseases symposium. Colon, January 1994].
    Z Kardiol; 1994; 83 Suppl 4():1-87. PubMed ID: 7856275
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibitors for cardiovascular therapy: recent advances at the Tenth World Congress of Cardiology Washington DC, September 14-19, 1986.
    Opie LH
    Cardiovasc Drugs Ther; 1987; 1(1):111-2. PubMed ID: 2908699
    [No Abstract]   [Full Text] [Related]  

  • 6. The place of angiotensin-converting enzyme inhibition in the treatment of cardiovascular diseases.
    Gavras H
    N Engl J Med; 1988 Dec; 319(23):1541-3. PubMed ID: 3185679
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of angiotensin-converting enzyme inhibitors in the therapy of cardiovascular disease: an overview.
    Chobanian A
    Angiology; 1989 Apr; 40(4 Pt 2):331-4. PubMed ID: 2705642
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibitors for the prevention and treatment of cardiovascular disease.
    Frishman WH
    Heart Dis; 2000; 2(3):183-4. PubMed ID: 11794142
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cardioprotection through ACE inhibition. Satellite symposium of the 12th scientific meeting of the International Society of Hypertension. 26 May 1988, Kyoto, Japan].
    Fortschr Med Suppl; 1988; 51():1-17. PubMed ID: 2904397
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin and the Heart. Symposium proceedings. Hamburg, October 22-24, 1992.
    Basic Res Cardiol; 1993; 88 Suppl 1():1-222. PubMed ID: 8102846
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prospective trends in the study of the therapeutic action of angiotensin-converting enzyme inhibitors in cardiovascular diseases].
    Novikova LS; Arabidze GG
    Ter Arkh; 1990; 62(1):118-23. PubMed ID: 2159193
    [No Abstract]   [Full Text] [Related]  

  • 12. [Endothelium--a new target for a therapeutic action of angiotensin-converting enzyme inhibitors].
    Karpov IuA
    Ter Arkh; 2004; 76(6):94-6. PubMed ID: 15332589
    [No Abstract]   [Full Text] [Related]  

  • 13. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology.
    López-Sendón J; Swedberg K; McMurray J; Tamargo J; Maggioni AP; Dargie H; Tendera M; Waagstein F; Kjekshus J; Lechat P; Torp-Pedersen C;
    Eur Heart J; 2004 Aug; 25(16):1454-70. PubMed ID: 15302105
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors.
    Weinberg MS; Weinberg AJ; Zappe DH
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):217-33. PubMed ID: 11881029
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in preventive cardiology: which drug to use and what to expect in light of the ONTARGET trial.
    Cairns JA
    Pol Arch Med Wewn; 2008 Jun; 118(6):335-8. PubMed ID: 18619187
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiotensin converting enzyme inhibition and its impact on cardiovascular disease.
    Gavras H
    Circulation; 1990 Jan; 81(1):381-8. PubMed ID: 2404627
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of angiotensin-converting enzyme inhibitors in chronic cardiac insufficiency (documents of XVI-XXI congresses of European Cardiologic Society)].
    Martynov AI; Stepura OB; Gadzhiev AN; Ivanova SV; Tomaeva FE
    Klin Med (Mosk); 2001; 79(4):71-4. PubMed ID: 11496749
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin converting enzyme inhibitor therapy.
    Róna G
    Ther Hung; 1991; 39(2):63-70. PubMed ID: 1948779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolongation of life with angiotensin converting enzyme inhibitor therapy.
    Torp-Pedersen C; Køber L
    Eur Heart J; 2000 Apr; 21(8):597-8. PubMed ID: 10731392
    [No Abstract]   [Full Text] [Related]  

  • 20. Endothelin-converting enzyme inhibitors: their application in cardiovascular diseases.
    Cerdeira AS; Brás-Silva C; Leite-Moreira AF
    Rev Port Cardiol; 2008 Mar; 27(3):385-408. PubMed ID: 18551924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.